Jump to content
RemedySpot.com

soy and breast cancer

Rate this topic


Guest guest

Recommended Posts

Guest guest

In a message dated 4/8/03 12:33:05 PM Mountain Daylight Time, Joyce@...

writes:

> Please advise where you got the information that soy has the potential to

> cause breast cancer.

> Thanks,

> Joyce A.

>

Joyce,

I think it is not " cause " but increases risk of.

Adrienne

Link to comment
Share on other sites

Guest guest

In a message dated 4/8/2003 12:43:00 PM Pacific Daylight Time,

duckblossm@... writes:

> Joyce,

> I think it is not " cause " but increases risk of.

> Adrienne

this is controversial.

soy contains phytoestrogens (plant estrogens) that are similar to the

estrogens produced by the human body (endogenous). however, phytoestrogens

are much, much weaker than the enogenous estrogens.

the phytoestrogens fill up the receptor sites for the endogenous estrogens,

causing more endogenously produced estrogen to be excreted from the body.

this is good because again the phytoestrogens are so much weaker than the

endogenous ones. thus, it is thought in premenapausal women, soy intake

DECREASES the risk of breast and other hormonally influenced cancers.

however, in post-menapausal women, who are producing very ittle estrogen,

it is possible that the phytoestrogens introduced by the soy, because they

are introducing estrogen into a system which has very little MIGHT increase

the risk of breast cancer.

stephanie

Link to comment
Share on other sites

  • 7 years later...
Guest guest

List,

In reviewing current medical literature (mostly human studies) on the

feared relationship between soy/genistein and breast cancer, I fail

to find anything alarming. I am not a fan of GMO soy, but I do find

many components of soy that are characterized by fear mongers as

horrible, are in fact quite useful for fighting cancer. One site

suggested on this list vilified the phytic acid component in soy. In

the general lack of balance or fairness in the article they neglected

to mention that the Satanic mineral-depleting phytic acid is the

selfsame compound as IP6 that has been beatified on other sites for

its miraculous cancer-fighting properties.

Others have suggested that only fermented soy should be used, but

this contains genistein which is in high concentration in Haelan, the

patented fermented soy drink that is used by many cancer patients who

can afford it.

About ten years ago I had a talk with Italian gynecologist-oncologist

Claudio D'Arrigo. We were both interested in the anti-cancer

properties found in pittosporum. He said that he found both

cancer-treating/preventing and cancer-causing/promoting compounds in

every plant he examined and he believed this to be a universal. At

the time I thought " those crazy Italians " but now I entertain some of

these same thoughts.

(abstracts below)

------------------

Nutr Cancer. 2009 Nov;61(6):792-8.

Early intake appears to be the key to the proposed protective effects

of soy intake against breast cancer.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Messina%20M%22%5BAuthor%5D>Messina

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hilakivi-e%20L%22%5BAuthor%5D>H\

ilakivi-e

L.

Loma University, Loma , California, USA. markm@...

Abstract

There is a large variation in breast cancer incidence and mortality

rates worldwide. Migration studies have indicated that this variation

is primarily the result of lifestyle influences. Although there has

been much research conducted, definitively identifying dietary

factors that impact breast cancer risk has proven difficult. In part

this may be because most clinical and epidemiologic studies have

focused on adult dietary exposure. However, evidence suggests that

childhood and/or adolescence is the period of life when the breast is

most sensitive to dietary influences. Further, the available

epidemiologic and animal data suggest that early soy intake reduces

breast cancer risk. Soy foods are unique dietary sources of

isoflavones, diphenolic compounds that exert estrogen-like effects

under certain experimental conditions. The protection effects of soy

may result from the soybean isoflavones stimulating differentiation

of the breast in much the same way that the elevated estrogen levels

do during pregnancy. More specifically, in rats, the primary

isoflavone genistein reduces mammary tumorigenesis and increases

mammary tissue differentiation by leading to a reduction in the

number of terminal end buds (TEB) and an increase in the number of

differentiated lobules. There is need and justification for continued

investigation of the early soy intake hypothesis, particularly to

determine the cellular targets of soy action and to identify the

signaling pathways mediating the effects on mammary gland morphology

and susceptibility to breast cancer.

PMID: 20155618 [PubMed - indexed for MEDLINE]

------------------------------------

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. Epub 2009 Apr 1.

Perspectives on the soy-breast cancer relation.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Messina%20M%22%5BAuthor%5D>Messina

M, <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wu%20AH%22%5BAuthor%5D>Wu AH.

Department of Nutrition, School of Public, Health, Loma

University, Loma , CA, USA. markm@...

Abstract

There has been considerable investigation of the potential for soy

foods to reduce risk of breast cancer. Initial enthusiasm for this

research was partially based on the historically low incidence rates

of breast cancer and high soy food intake in Japan. There are several

putative soybean chemopreventive agents, but most cancer research has

focused on isoflavones. Isoflavones possess both hormonal and

nonhormonal properties relevant to carcinogenesis. Recent

epidemiologic analyses indicate that among Asians high soy intake is

associated with an approximate one-third reduction in the risk of

both pre- and postmenopausal breast cancer. However, several lines of

evidence suggest that to derive maximum protection against breast

cancer, soy must be consumed early in life. This evidence is

consistent with the lack of significant effects noted in clinical

studies that have evaluated the effects of isoflavone-containing

products on breast cancer risk markers. Isoflavones may exert their

putative protective effects by stimulating breast cell

differentiation in a manner similar to that which is thought to occur

during early pregnancy. Finally, the ability of the isoflavone

genistein to stimulate the growth of mammary tumors in ovariectomized

athymic nude mice implanted with estrogen-sensitive breast cancer

cells has raised concern that soy foods, and especially isoflavone

supplements, are contraindicated for patients with breast cancer and

women at high risk of breast cancer. However, findings from clinical

studies, in which breast biopsies have been taken or breast tissue

density measured after isoflavone exposure, are reassuring and

contrast with the proliferative effects of conventional combined

hormone therapy, although understanding of the effect of soy and

isoflavones on breast tissues remains imprecise.

PMID: 19339397 [PubMed - indexed for MEDLINE]

----------------------------------------

J Epidemiol. 2010 Mar 5;20(2):83-9. Epub 2010 Feb 20.

Factors to consider in the association between soy isoflavone intake

and breast cancer risk.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Nagata%20C%22%5BAuthor%5D>Nagata C.

Department of Epidemiology & Preventive Medicine, Gifu University

Graduate School of Medicine, Yanagido, Gifu, Japan. chisato@...

Abstract

It has been suggested that soy isoflavones have protective effects

against breast cancer. However, data from epidemiological studies are

not conclusive. A recent meta-analysis showed that soy intake was

inversely associated with breast cancer risk in Asian but not Western

populations, which indicates that protection against breast cancer

may require that women consume levels of soy typical in Asian diets.

In addition to the amount of soy isoflavones consumed, the form and

food source of isoflavones, timing of isoflavone exposure, estrogen

receptor status of tumors, and equol-producer status and hormonal

profile of individuals may modify the association between soy

isoflavone intake and the risk of breast cancer. These factors might

explain the heterogeneity of results from studies. This present

report contrasts background data from Japanese and Western women to

identify the potential modifying of these factors.

PMID: 20173308 [PubMed - indexed for MEDLINE]

---------------------------

J Clin Oncol. 2008 Apr 1;26(10):1677-83. Epub 2008 Mar 3.

Plasma isoflavone level and subsequent risk of breast cancer among

Japanese women: a nested case-control study from the Japan Public

Health Center-based prospective study group.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Iwasaki%20M%22%5BAuthor%5D>Iwasaki

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Inoue%20M%22%5BAuthor%5D>Inoue

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Otani%20T%22%5BAuthor%5D>Otani

T,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sasazuki%20S%22%5BAuthor%5D>Sasazuki

S,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kurahashi%20N%22%5BAuthor%5D>Kurahas\

hi

N,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Miura%20T%22%5BAuthor%5D>Miura

T,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Yamamoto%20S%22%5BAuthor%5D>Yamamoto

S,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tsugane%20S%22%5BAuthor%5D>Tsugane

S;

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Japan%20Public%20Health%20Center-bas\

ed%20prospective%20study%20group%22%5BCorporate%20Author%5D>Japan

Public Health Center-based prospective study group.

Epidemiology and Prevention Division, Research Center for Cancer

Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji,

Chuo-ku, Tokyo, 104-0045, Japan. moiwasak@...

Abstract

PURPOSE: Because they have large variations in consumption, Asian

countries are suitable settings for studies of the effect of

relatively high-dose isoflavone intake on breast cancer risk.

Nevertheless, no prospective study from Asia has assessed blood or

urine levels as biomarkers of isoflavone intake. PATIENTS AND

METHODS: A total of 24,226 women ages 40 to 69 years in the Japan

Public Health Center-based prospective study who responded to the

baseline questionnaire and provided blood in 1990 to 1995 were

observed to December 2002. During a mean 10.6 years of follow-up, 144

patients newly diagnosed with breast cancer were identified. Two

matched controls for each patient were selected from the cohort.

Isoflavone levels were assessed by plasma level and food frequency

questionnaire, and the odds ratio of breast cancer according to

isoflavone level was estimated using a conditional logistic

regression model. RESULTS: We found a statistically significant

inverse association between plasma genistein and risk of breast

cancer, but no association for plasma daidzein. Adjusted odds ratios

for the highest versus lowest quartile of plasma level were 0.34 for

genistein (95% CI, 0.16 to 0.74; P for trend, .02) and 0.71 for

daidzein (95% CI, 0.35 to 1.44; P for trend, .54). Median plasma

genistein values in the control group were 31.9 ng/mL for the lowest

and 353.9 ng/mL for the highest quartile groups. Regarding dietary

intake of isoflavones, nonsignificant inverse associations were

observed for both genistein and daidzein. CONCLUSION: This nested

case-control study found an inverse association between plasma

genistein and the risk of breast cancer in Japan.

PMID: 18316793 [PubMed - indexed for MEDLINE]

---------------------------

Br J Cancer. 2008 Jan 15;98(1):9-14. Epub 2008 Jan 8.

Epidemiology of soy exposures and breast cancer risk.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wu%20AH%22%5BAuthor%5D>Wu

AH,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Yu%20MC%22%5BAuthor%5D>Yu

MC,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tseng%20CC%22%5BAuthor%5D>Tseng

CC,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pike%20MC%22%5BAuthor%5D>Pike MC.

Department of Preventive Medicine, Keck School of Medicine,

University of Southern California, Los Angeles, CA 90089-9175, USA.

annawu@...

Abstract

Most of the early studies published on soy and breast cancer were not

designed to test the effect of soy; the assessment of soy intake was

usually crude and few potential confounders were considered in the

analysis. In this review, we focused on studies with relatively

complete assessment of dietary soy exposure in the targeted

populations and appropriate consideration for potential confounders

in the statistical analysis of study data. Meta-analysis of the 8 (1

cohort, 7 case-control) studies conducted in high-soy-consuming

Asians show a significant trend of decreasing risk with increasing

soy food intake. Compared to the lowest level of soy food intake

(<or=5 mg isoflavones per day), risk was intermediate (OR=0.88, 95%

confidence interval (CI)=0.78-0.98) among those with modest (

approximately 10 mg isoflavones per day) intake and lowest (OR=0.71,

95% CI=0.60-0.85) among those with high intake (>or=20 mg isoflavones

per day). In contrast, soy intake was unrelated to breast cancer risk

in studies conducted in the 11 low-soy-consuming Western populations

whose average highest and lowest soy isoflavone intake levels were

around 0.8 and 0.15 mg per day, respectively. Thus, the evidence to

date, based largely on case-control studies, suggest that soy food

intake in the amount consumed in Asian populations may have

protective effects against breast cancer.

PMID: 18182974 [PubMed - indexed for MEDLINE]

Link to comment
Share on other sites

Guest guest

,

I have felt so grateful that there is someone out there who really knows what's

going on regarding cancer treatments etc and I'm very happy to read that you're

doing well!  I was wondering what you thought about using Tofu (store bought

not fermented) after having breast cancer. Thanks,

________________________________

From: VGammill <vgammill@...>

Sent: Mon, June 21, 2010 1:02:16 PM

Subject: [ ] soy and breast cancer

 

List,

In reviewing current medical literature (mostly human studies) on the

feared relationship between soy/genistein and breast cancer, I fail

to find anything alarming. I am not a fan of GMO soy, but I do find

many components of soy that are characterized by fear mongers as

horrible, are in fact quite useful for fighting cancer. One site

suggested on this list vilified the phytic acid component in soy. In

the general lack of balance or fairness in the article they neglected

to mention that the Satanic mineral-depleting phytic acid is the

selfsame compound as IP6 that has been beatified on other sites for

its miraculous cancer-fighting properties.

Others have suggested that only fermented soy should be used, but

this contains genistein which is in high concentration in Haelan, the

patented fermented soy drink that is used by many cancer patients who

can afford it.

About ten years ago I had a talk with Italian gynecologist-oncologist

Claudio D'Arrigo. We were both interested in the anti-cancer

properties found in pittosporum. He said that he found both

cancer-treating/preventing and cancer-causing/promoting compounds in

every plant he examined and he believed this to be a universal. At

the time I thought " those crazy Italians " but now I entertain some of

these same thoughts.

(abstracts below)

------------------

Nutr Cancer. 2009 Nov;61(6):792-8.

Early intake appears to be the key to the proposed protective effects

of soy intake against breast cancer.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Messina%20M%22%5BAuthor%5D>Messina

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hilakivi-e%20L%22%5BAuthor%5D>H\

ilakivi-e

L.

Loma University, Loma , California, USA. markm@...

Abstract

There is a large variation in breast cancer incidence and mortality

rates worldwide. Migration studies have indicated that this variation

is primarily the result of lifestyle influences. Although there has

been much research conducted, definitively identifying dietary

factors that impact breast cancer risk has proven difficult. In part

this may be because most clinical and epidemiologic studies have

focused on adult dietary exposure. However, evidence suggests that

childhood and/or adolescence is the period of life when the breast is

most sensitive to dietary influences. Further, the available

epidemiologic and animal data suggest that early soy intake reduces

breast cancer risk. Soy foods are unique dietary sources of

isoflavones, diphenolic compounds that exert estrogen-like effects

under certain experimental conditions. The protection effects of soy

may result from the soybean isoflavones stimulating differentiation

of the breast in much the same way that the elevated estrogen levels

do during pregnancy. More specifically, in rats, the primary

isoflavone genistein reduces mammary tumorigenesis and increases

mammary tissue differentiation by leading to a reduction in the

number of terminal end buds (TEB) and an increase in the number of

differentiated lobules. There is need and justification for continued

investigation of the early soy intake hypothesis, particularly to

determine the cellular targets of soy action and to identify the

signaling pathways mediating the effects on mammary gland morphology

and susceptibility to breast cancer.

PMID: 20155618 [PubMed - indexed for MEDLINE]

------------------------------------

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. Epub 2009 Apr 1.

Perspectives on the soy-breast cancer relation.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Messina%20M%22%5BAuthor%5D>Messina

M, <http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wu%20AH%22%5BAuthor%5D>Wu AH.

Department of Nutrition, School of Public, Health, Loma

University, Loma , CA, USA. markm@...

Abstract

There has been considerable investigation of the potential for soy

foods to reduce risk of breast cancer. Initial enthusiasm for this

research was partially based on the historically low incidence rates

of breast cancer and high soy food intake in Japan. There are several

putative soybean chemopreventive agents, but most cancer research has

focused on isoflavones. Isoflavones possess both hormonal and

nonhormonal properties relevant to carcinogenesis. Recent

epidemiologic analyses indicate that among Asians high soy intake is

associated with an approximate one-third reduction in the risk of

both pre- and postmenopausal breast cancer. However, several lines of

evidence suggest that to derive maximum protection against breast

cancer, soy must be consumed early in life. This evidence is

consistent with the lack of significant effects noted in clinical

studies that have evaluated the effects of isoflavone-containing

products on breast cancer risk markers. Isoflavones may exert their

putative protective effects by stimulating breast cell

differentiation in a manner similar to that which is thought to occur

during early pregnancy. Finally, the ability of the isoflavone

genistein to stimulate the growth of mammary tumors in ovariectomized

athymic nude mice implanted with estrogen-sensitive breast cancer

cells has raised concern that soy foods, and especially isoflavone

supplements, are contraindicated for patients with breast cancer and

women at high risk of breast cancer. However, findings from clinical

studies, in which breast biopsies have been taken or breast tissue

density measured after isoflavone exposure, are reassuring and

contrast with the proliferative effects of conventional combined

hormone therapy, although understanding of the effect of soy and

isoflavones on breast tissues remains imprecise.

PMID: 19339397 [PubMed - indexed for MEDLINE]

----------------------------------------

J Epidemiol. 2010 Mar 5;20(2):83-9. Epub 2010 Feb 20.

Factors to consider in the association between soy isoflavone intake

and breast cancer risk.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Nagata%20C%22%5BAuthor%5D>Nagata C.

Department of Epidemiology & Preventive Medicine, Gifu University

Graduate School of Medicine, Yanagido, Gifu, Japan. chisato@...

Abstract

It has been suggested that soy isoflavones have protective effects

against breast cancer. However, data from epidemiological studies are

not conclusive. A recent meta-analysis showed that soy intake was

inversely associated with breast cancer risk in Asian but not Western

populations, which indicates that protection against breast cancer

may require that women consume levels of soy typical in Asian diets.

In addition to the amount of soy isoflavones consumed, the form and

food source of isoflavones, timing of isoflavone exposure, estrogen

receptor status of tumors, and equol-producer status and hormonal

profile of individuals may modify the association between soy

isoflavone intake and the risk of breast cancer. These factors might

explain the heterogeneity of results from studies. This present

report contrasts background data from Japanese and Western women to

identify the potential modifying of these factors.

PMID: 20173308 [PubMed - indexed for MEDLINE]

---------------------------

J Clin Oncol. 2008 Apr 1;26(10):1677-83. Epub 2008 Mar 3.

Plasma isoflavone level and subsequent risk of breast cancer among

Japanese women: a nested case-control study from the Japan Public

Health Center-based prospective study group.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Iwasaki%20M%22%5BAuthor%5D>Iwasaki

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Inoue%20M%22%5BAuthor%5D>Inoue

M,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Otani%20T%22%5BAuthor%5D>Otani

T,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Sasazuki%20S%22%5BAuthor%5D>Sasazuki

S,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Kurahashi%20N%22%5BAuthor%5D>Kurahas\

hi

N,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Miura%20T%22%5BAuthor%5D>Miura

T,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Yamamoto%20S%22%5BAuthor%5D>Yamamoto

S,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tsugane%20S%22%5BAuthor%5D>Tsugane

S;

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Japan%20Public%20Health%20Center-bas\

ed%20prospective%20study%20group%22%5BCorporate%20Author%5D>Japan

Public Health Center-based prospective study group.

Epidemiology and Prevention Division, Research Center for Cancer

Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji,

Chuo-ku, Tokyo, 104-0045, Japan. moiwasak@...

Abstract

PURPOSE: Because they have large variations in consumption, Asian

countries are suitable settings for studies of the effect of

relatively high-dose isoflavone intake on breast cancer risk.

Nevertheless, no prospective study from Asia has assessed blood or

urine levels as biomarkers of isoflavone intake. PATIENTS AND

METHODS: A total of 24,226 women ages 40 to 69 years in the Japan

Public Health Center-based prospective study who responded to the

baseline questionnaire and provided blood in 1990 to 1995 were

observed to December 2002. During a mean 10.6 years of follow-up, 144

patients newly diagnosed with breast cancer were identified. Two

matched controls for each patient were selected from the cohort.

Isoflavone levels were assessed by plasma level and food frequency

questionnaire, and the odds ratio of breast cancer according to

isoflavone level was estimated using a conditional logistic

regression model. RESULTS: We found a statistically significant

inverse association between plasma genistein and risk of breast

cancer, but no association for plasma daidzein. Adjusted odds ratios

for the highest versus lowest quartile of plasma level were 0.34 for

genistein (95% CI, 0.16 to 0.74; P for trend, .02) and 0.71 for

daidzein (95% CI, 0.35 to 1.44; P for trend, .54). Median plasma

genistein values in the control group were 31.9 ng/mL for the lowest

and 353.9 ng/mL for the highest quartile groups. Regarding dietary

intake of isoflavones, nonsignificant inverse associations were

observed for both genistein and daidzein. CONCLUSION: This nested

case-control study found an inverse association between plasma

genistein and the risk of breast cancer in Japan.

PMID: 18316793 [PubMed - indexed for MEDLINE]

---------------------------

Br J Cancer. 2008 Jan 15;98(1):9-14. Epub 2008 Jan 8.

Epidemiology of soy exposures and breast cancer risk.

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Wu%20AH%22%5BAuthor%5D>Wu

AH,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Yu%20MC%22%5BAuthor%5D>Yu

MC,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Tseng%20CC%22%5BAuthor%5D>Tseng

CC,

<http://www.ncbi.nlm.nih.gov/pubmed?term=%22Pike%20MC%22%5BAuthor%5D>Pike MC.

Department of Preventive Medicine, Keck School of Medicine,

University of Southern California, Los Angeles, CA 90089-9175, USA.

annawu@...

Abstract

Most of the early studies published on soy and breast cancer were not

designed to test the effect of soy; the assessment of soy intake was

usually crude and few potential confounders were considered in the

analysis. In this review, we focused on studies with relatively

complete assessment of dietary soy exposure in the targeted

populations and appropriate consideration for potential confounders

in the statistical analysis of study data. Meta-analysis of the 8 (1

cohort, 7 case-control) studies conducted in high-soy-consuming

Asians show a significant trend of decreasing risk with increasing

soy food intake. Compared to the lowest level of soy food intake

(<or=5 mg isoflavones per day), risk was intermediate (OR=0.88, 95%

confidence interval (CI)=0.78-0.98) among those with modest (

approximately 10 mg isoflavones per day) intake and lowest (OR=0.71,

95% CI=0.60-0.85) among those with high intake (>or=20 mg isoflavones

per day). In contrast, soy intake was unrelated to breast cancer risk

in studies conducted in the 11 low-soy-consuming Western populations

whose average highest and lowest soy isoflavone intake levels were

around 0.8 and 0.15 mg per day, respectively. Thus, the evidence to

date, based largely on case-control studies, suggest that soy food

intake in the amount consumed in Asian populations may have

protective effects against breast cancer.

PMID: 18182974 [PubMed - indexed for MEDLINE]

Link to comment
Share on other sites

Guest guest

,

You can answer this question yourself by seeing

if it will pass the laugh test. Say: " Poor

, she died because she ate a serving of

store-bought tofu in a moment of weakness. " If

it sounds too silly for words, then it is too silly for words.

Thank you for the compliment. I am doing well at

the moment, but like everyone else, I fear a shift in the wind.

At 10:17 AM 6/25/2010, you wrote:

>

>,

>I have felt so grateful that there is someone

>out there who really knows what's going on

>regarding cancer treatments etc and I'm very

>happy to read that you're doing well! Â I was

>wondering what you thought about using Tofu

>(store bought not fermented) after having breast cancer. Thanks,

Link to comment
Share on other sites

Guest guest

Hi ,

Yes, that would be silly, I used to eat alot of tofu (much in Asian recipes) and

wondered if the Dr's warning about it was valid. I pray that you continue on

your path to perfect health. Sincerely,

From: VGammill

Sent: Fri, June 25, 2010

Subject: Re: [ ] soy and breast cancer

 

,

You can answer this question yourself by seeing

if it will pass the laugh test. Say: " Poor

, she died because she ate a serving of

store-bought tofu in a moment of weakness. " If

it sounds too silly for words, then it is too silly for words.

Thank you for the compliment. I am doing well at

the moment, but like everyone else, I fear a shift in the wind.

At 10:17 AM 6/25/2010, you wrote:

>

>,

>I have felt so grateful that there is someone

>out there who really knows what's going on

>regarding cancer treatments etc and I'm very

>happy to read that you're doing well! I was

>wondering what you thought about using Tofu

>(store bought not fermented) after having breast cancer. Thanks,

Link to comment
Share on other sites

Guest guest

Soy that has not been fermented is a poison !

http://www.naturalhealthstrategies.com/dangers-of-soy.html

http://www.soyonlineservice.co.nz/03soymyths.htm

Please don't eat non fermented soy.

Vicki

> >

> >,

> >I have felt so grateful that there is someone

> >out there who really knows what's going on

> >regarding cancer treatments etc and I'm very

> >happy to read that you're doing well! I was

> >wondering what you thought about using Tofu

> >(store bought not fermented) after having breast cancer. Thanks,

>

Link to comment
Share on other sites

Guest guest

At 07:59 AM 6/26/2010, Vicki wrote:

>

>Soy that has not been fermented is a poison !

Vicki, I think that you are overstating the case. How is unfermented

soy more toxic than the standard American diet that is saturated with

high fructose corn syrup, trans fats, preservatives, colorants,

bromide " conditioners, " BPA, fluoride, genetically-modified

mysteries, antibiotics and endocrine disrupters? Unfermented soy is

less toxic than virtually all the millions of lbs of medicines that

Americans lap up each year.

Sure there are thousands of healthier things to eat than unfermented

soy and almost all of them taste better too. Having a few chunks of

tofu in your miso is such an absolute non-issue compared to the

smarmy financial relationship of the B. Komen Foundation and

Kentucky Fried Chicken.

http://blogs.laweekly.com/squidink/fast-food/kfc-susan-komen-deceptive-ad-c/

What's next, the American Cancer Society slipping into bed with

Marlboro cigarettes?

Link to comment
Share on other sites

Guest guest

Thank you for the info, I had no idea that unfermented soy wasn't a

healthy alternative to meat.

________________________________

From: VGammill <vgammill@...>

Sent: Sat, June 26, 2010 10:10:28 AM

Subject: Re: [ ] Re: soy and breast cancer

 

At 07:59 AM 6/26/2010, Vicki wrote:

>

>Soy that has not been fermented is a poison !

Vicki, I think that you are overstating the case. How is unfermented

soy more toxic than the standard American diet that is saturated with

high fructose corn syrup, trans fats, preservatives, colorants,

bromide " conditioners, " BPA, fluoride, genetically-modified

mysteries, antibiotics and endocrine disrupters? Unfermented soy is

less toxic than virtually all the millions of lbs of medicines that

Americans lap up each year.

Sure there are thousands of healthier things to eat than unfermented

soy and almost all of them taste better too. Having a few chunks of

tofu in your miso is such an absolute non-issue compared to the

smarmy financial relationship of the B. Komen Foundation and

Kentucky Fried Chicken.

http://blogs.laweekly.com/squidink/fast-food/kfc-susan-komen-deceptive-ad-c/

What's next, the American Cancer Society slipping into bed with

Marlboro cigarettes?

Link to comment
Share on other sites

Guest guest

Long-time vegetarian here. I always love reading about soy.

Here's the deal - I, personally, won't eat a lot of it because I'm severely

allergic to it.

Now, don't believe the media hype about it being good for you - it's not.

The Asians know how to eat soy - fermented and in small amounts.

Americans will have soy milk in their cereal or coffee, then have tofu burgers

at lunch, and then eat baked tofu full of flavorings and gunk for dinner.

Nothing about this is healthy.

But, as a treat once in awhile, why not?

Will eating soy cause estrogen positive breast cancer to grow? Who really

knows? Certainly not the experts. There is a woman in England (she wrote a

book, but don't expect me to remember who she is), who has had something like

three recurrances of breast cancer. She said her third recurrance was her last

because she has eliminated all dairy from her life and she is eating tons and

tons of soy (and not the fermented kind). She says she made it through chemo

without losing her hair because of her diet.

As with all things, it's a personal choice once you have the facts. There is

nothing processed that is going to be good for you if you eat it all the time.

Also, large amounts of soy may inhibit your thyroid. And, it is one of the

number one allergens out there.

ar

Link to comment
Share on other sites

Guest guest

Look at what was written: " she ate a serving of store-bought tofu in a moment

of weakness. " and you will see it speaks to 'a' portion, not a steady diet

and I suppose was said to help people avoid thrashing themselves for that

" moment of weakness " creating such guilt that the tension created would do more

harm than that " portion " of anything. If our fate revolves around 'a'

anything, we are in trouble because walking down any street will result in the

inhalation of toxins from any number is sources.

Joe C.

From: VGammill

Sent: Friday, June 25, 2010 2:41 PM

Subject: Re: [ ] soy and breast cancer

,

You can answer this question yourself by seeing

if it will pass the laugh test. Say: " Poor

, she died because she ate a serving of

store-bought tofu in a moment of weakness. " If

it sounds too silly for words, then it is too silly for words.

Thank you for the compliment. I am doing well at

the moment, but like everyone else, I fear a shift in the wind.

At 10:17 AM 6/25/2010, you wrote:

>

>,

>I have felt so grateful that there is someone

>out there who really knows what's going on

>regarding cancer treatments etc and I'm very

>happy to read that you're doing well! Â I was

>wondering what you thought about using Tofu

>(store bought not fermented) after having breast cancer. Thanks,

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...